Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to cyclopentano-hydrophenanthrene ; derivative thereof
Patent
1991-05-01
1995-03-28
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to cyclopentano-hydrophenanthrene ; derivative thereof
424 165, 424 169, 424 4, 424 9, A61K 4900, A61K 4902, A61K 4904
Patent
active
054014891
ABSTRACT:
Biomodulators, optionally linked to imaging-active moieties, can be administered to a host to enhance images thereof, e.g., NMR-, X-ray- or radio-images, preferably by increasing aberrant tissue signal intensity. Biomodulators can also condition tissue to enhance uptake of otherwise non-specific imaging agents. When linked to drugs, biomodulators can target the same to particular sites in the body.
REFERENCES:
patent: 5021427 (1991-06-01), Elbein et al.
patent: 5047227 (1991-09-01), Rodwell et al.
patent: 5240693 (1993-08-01), Born et al.
patent: 5277892 (1994-01-01), Rhodes
Mann et al., "Cell Surface Oligosaccharide Modulation during Differentiation: IV. Normal and Transformed Cell Growth Control," Mechanisms of Ageing and Development, 44 (1988), pp. 17-33.
Thakur et al., J. Immun. Methods, vol. 152 (1992) pp. 209-216.
Born Jerry L.
Eshima Dennis
Mann Paul L.
Matwiyoff Nicholas A.
Covert John M.
Stoll Robert L.
University of New Mexico
LandOfFree
Biomodulators as universal imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomodulators as universal imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomodulators as universal imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2248736